NorthWest Biotherapeutics Inc (NWBO)

[Hopeforthefuture3]

David, your scenario makes logical sense. If primary and secondary endpoints all a success then it is very logical to release tld asap and start work on a bla. Let the journal article come when ready and would imo be published faster as medical world would want to see the details on such a breakthrough as told from tld release. Those dismissing such logic can't (or won't) show any examples supporting their position.
Dave Innes reportedly compared the tld reported by CVM without a technical paper to nwbo and why they are waiting for a published paper. Well CVM released tld on a trial that failed the primary endpoint - I hope this is not a good comparison. The cvm trial did have ok results (good, not great) on a secondary endpoint. In such a case I can logically see the need for a paper.
Companies that have succesful primary and secondary results in my experience share that with the world. Look at AMRN when they completed results from their very large study with succesful primary and nearly all secondary endpoints announced tld and on that announcement to stock quadrupled in a day. Published paper and the detail came a few months later and is very impressive. That imo is how to share results from a successful trial. Amrn later lost it all back when they lost the patent trial - unfair result in my opinion.
In the meantime with nwbo we wait near 52 week lows, who knows what we will see today.
My covid vaccine stock NVAX on the other hand is (at least in premarket) up 90 points in the last 5 weeks now at 210 - was 120 when false rumor of manufacturing troubles was released by an 'anomous' source 5 weeks ago. Company quickly refused the false rumor - not afraid to protect themselves from false attacks.
Let's see examples from those criticizing your logic
BTW I still think nwbo will succeed on primary but your logic does make sense and I have no reasonable explanation why no tld
Good luck